MAPK3 and cancer: It has been demonstrated that L-thyroxine (T4) binds the cell surface receptor on integrin αvβ3 and subsequently regulates cancer cell proliferation, angiogenesis and metastasis via the MAPK (ERK1 and ERK2 cascade) pathway [30].